A deadly fungal pathogen developed the ability to resist all existing antifungal drugs on three separate occasions in the United States, according to a new report.
The fungus, Candida auris, was already classified as an “urgent threat” by the Centers for Disease Control and Prevention. But the emergence of so called “pan-resistant” strains raises additional concern, according to the report’s authors, who are infectious disease specialists at the CDC and the New York State Department of Health. They published their findings Thursday in the CDC’s publication Morbidity and Mortality Weekly Report.
Somewhere between 30 percent and 60 percent of patients die from the infection. (Determining the exact fatality rate is tricky because the fungus often preys upon patients already suffering from life-threatening conditions.)
Submitted by, TheAristocrats.